Intuitive Surgical removed from Focus List at Citi

Citi remover Intuitive Surgical from the firm’s Focus List while keeping a Buy rating on the shares with a $462 price target. The firm also removed the stock’s “Top Pick designation” saying we have moved from robot anticipation to the da Vinci 5 launch. Management reiterated expectations for a limited launch through early 2025 as it works through supply chain challenges and enhanced features, the analyst tells investors in a research note.